Joel Lamstein Named New Chair of Dean’s Advisory Board
Joel Lamstein was appointed as the new Chair of the Dean’s Advisory Board on January 1, 2016.
Lamstein is president and co-founder of John Snow, Inc. (JSI), a public health management consulting and research organization based in Boston.
He also serves as president of World Education, Inc., a nonprofit organization dedicated to improving the lives of the poor through education, economic, and social development programs. In 1973, Lamstein co-founded Management Sciences for Health (MSH), a private, nonprofit international organization working in public health areas to strengthen health care management and improve access.
Lamstein is a senior lecturer at the Harvard T.H. Chan School of Public Health and has lectured at public health school throughout the country.
In 2009, Lamstein received the CEO Social Leadership Award, a program funded by the Lewis Family Foundation and given by the Boston Business Journal. He holds a BS in Math and Physics from the University of Michigan and attended the MIT Sloan School of Management.
In 2012, Lamstein committed to endowing the Lamstein Family/JSI Scholarship to support one or more annual scholarship awards to MPH students at BUSPH. JSI has long been a source of practicums for BUSPH students as well as jobs for graduates.
“I am honored to be appointed the chair of the Advisory Board,” Lamstein says. “BU, always an important part of the public health community, is poised to play an even more substantive role under the visionary leadership of Dean Galea.”
In addition to the BUSPH Dean’s Advisory Board, Lamstein also serves on the advisory boards of the University of Michigan School of Public Health and the Harvard Center for Population and Development Studies, as well as the board of Physicians for Human Rights and the advisory council of the Children’s Health Fund in New York. From 2004 to 2012, he served on the board of the Global Health Council.
The DAB, a group of prominent alumni and friends of BUSPH, works with Dean Sandro Galea and other School leaders on strategy and resource development. The other members of the DAB are:
- Andrew Dreyfus – President and CEO, Massachusetts Blue Cross Blue Shield
- Jeannine M. Rivet (’81) – Executive Vice President, UnitedHealth Group
- John P. Howe III, MD – Retired, President and CEO, Project HOPE
- Kevin C. Phelan – President, Colliers International Inc.
- Paul L. Rosenberg – Partner, The Bridgespan Group
- Christine S. Hunter, MD – Chief Medical Officer, US Office of Personnel Management
- James Sherblom – Owner, Seaflower Associates
- Michael J. Taylor – Senior Vice President, Aon Hewitt
- Susan Garfield (’11) – Principal, Ernst & Young LLP
- Donato Tramuto – Founder, President and CEO, Physicians Interactive LLC
- Charles L. Donahue Jr. (’12) – Health Care Consultant, Health Policy
- Betsy Lahue (’99) – Vice President of Strategic Marketing, Health Economics and Outcomes Research, BD Ventures
- Cristin Lis – Senior Vice President of Corporate Affairs, Global Blood Therapeutics
- Timothy Murphy – CEO, Beacon Health Strategies
- Elizabeth Olek, DO (’02) – Senior Medical Director, Puma Biotechnology Inc.
- Zubeen Shroff – Managing Partner, Galen Management
- Philip Reilly, MD, JD – Venture Partner, Third Rock Ventures
- Sheldon N. Simon – Partner and Equity Analyst, Adage Capital Management LP